Across United States health care settings, which class of medications is consistently identified as the leading cause of medication-related adverse events?

Prepare for the American Board of Family Medicine Exam. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Across United States health care settings, which class of medications is consistently identified as the leading cause of medication-related adverse events?

Explanation:
Bleeding risk from anticoagulants drives the high rate of medication-related adverse events. These drugs suppress the body’s ability to form clots, so even small changes in dose, drug interactions, or dietary factors can push a patient into serious or life-threatening bleeding. Warfarin exemplifies this challenge with its numerous drug and food interactions and the need for regular INR monitoring to stay within a narrow therapeutic window. Direct oral anticoagulants reduce some interactions but still carry a meaningful risk of major bleeding and require awareness of renal function and specific reversal strategies if bleeding occurs. In real-world practice, a sizable share of preventable adverse events stem from anticoagulants because bleeding can be sudden and severe, often necessitating hospitalization or urgent care, particularly among older patients on multiple medications. While antibiotics, antihypertensives, and statins have their own adverse effects, none match the consistent, high-risk bleeding profile that anticoagulants contribute across care settings. To lessen risk, use appropriate indications, start at recommended doses, monitor when needed, review interacting medications (like NSAIDs or antiplatelets), educate patients on warning signs of bleeding, and plan for perioperative management and rapid reversal if needed.

Bleeding risk from anticoagulants drives the high rate of medication-related adverse events. These drugs suppress the body’s ability to form clots, so even small changes in dose, drug interactions, or dietary factors can push a patient into serious or life-threatening bleeding. Warfarin exemplifies this challenge with its numerous drug and food interactions and the need for regular INR monitoring to stay within a narrow therapeutic window. Direct oral anticoagulants reduce some interactions but still carry a meaningful risk of major bleeding and require awareness of renal function and specific reversal strategies if bleeding occurs. In real-world practice, a sizable share of preventable adverse events stem from anticoagulants because bleeding can be sudden and severe, often necessitating hospitalization or urgent care, particularly among older patients on multiple medications.

While antibiotics, antihypertensives, and statins have their own adverse effects, none match the consistent, high-risk bleeding profile that anticoagulants contribute across care settings. To lessen risk, use appropriate indications, start at recommended doses, monitor when needed, review interacting medications (like NSAIDs or antiplatelets), educate patients on warning signs of bleeding, and plan for perioperative management and rapid reversal if needed.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy